Abstract
Even though the relationship between syntax score (SS) and coronary no-reflow phenomenon has been studied, the relation between SS and syntax score II (SS II) in patients with no-reflow phenomenon is unknown. We aimed to define the relationship between coronary no-reflow phenomenon and SS II as compared with SS. This study enrolled 193 patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in whom 42 patients developed the no-reflow phenomenon. SS and SS II were calculated in all patients. Bland Altman analysis was used to compare receiver-operating characteristic (ROC) curve analysis results. SS and SS II values were significantly higher in the no-reflow group than the reflow group (28.3 ± 5.5 vs. 18.8 ± 10.1; p < 0.001 and 42.5 (22.1–58.5) vs. 26.1 (13–49.8); p < 0.001 respectively). SS II value >32.3 yielded an area under the curve value of 0.881 (95% CI 0.820–0.942; p < 0.001) and independently predicted no-reflow with a sensitivity of 88% and a specificity of 80% (OR 1.150, 95% CI 1.047–1.263, p = 0.003). Comparison of ROC curve results with Bland Altman analysis showed that area under curve of SS II was larger than that of SS (0.881 vs. 0.785, p = 0.01). SS II may be a more useful tool than SS for prediction no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10554-017-1200-5/MediaObjects/10554_2017_1200_Fig1_HTML.gif)
Similar content being viewed by others
References
Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110:e82–e292
Niccoli G, Burzotta F, Galiuto L et al (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281–292. doi:10.1016/j.jacc.2009.03.054
Ito H, Iwakura K (1998) Assessing the relation between coronary reflow and myocardial reflow. Am J Cardiol 81(12A):8G–12G
Morice MC, Serruys PW, Kappetein AP et al (2010) Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121:2645–2653
Farooq V, van Klaveren D, Steyerberg EW et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381:639–650
Şahin DY, Gür M, Elbasan Z et al (2013) SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 24(2):148–153. doi:10.1097/MCA.0b013e32835c4719
Ndrepepa G, Tiroch K, Fusaro M et al (2010) 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383–2389
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segmentelevation. Eur Heart J 33(20):2569–2619. doi:10.1093/eurheartj/ehs215
Gibson CM, Cannon CP, Murphy SA et al (2002) Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to longterm outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105:1909–1913
Magro M, Nauta ST, Simsek C et al (2012) Usefulness of the SYNTAX score to predict ‘no reflow’ in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 109:601–606
Jaffe R, Charron T, Puley G et al (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117:3152–3156
Topol EJ, Yadav JS (2000) Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101:570–580
Jaffe R, Charron T, Puley G et al (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117(24):3152–3156. doi:10.1161/CIRCULATIONAHA.107.742312
Şahin DY et al (2013) SYNTAX score is a predictor of angiographic no-reflow patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 24:148–153
Fearon WF, Shah M, Ng M et al (2008) Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 51:560–565
Demirbag R, Yilmaz R, Gur M et al (2005) Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res 578:298–307
Gupta S, Gupta MM (2016) No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J 68(4):539–551
Dragu R, Behar S, Sandach A et al (2006) Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 97(8):1142–1145
Sensoy B, Uzunget SB, Acikgoz S et al (2016) Renal dysfunction on admission predicts no-reflow phenomenon in patients undergoing manual thrombus aspiration during primary percutaneous coronary intervention. Zhonghua Minguo Xin Zang Xue Hui Za Zhi 32(2):185–193
Iwakura K, Ito H, Ikushima M et al (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41(1):1–7
Liang BM, Xu ZB, Yi Q et al (2013) Association of chronic obstructive pulmonary disease with coronary artery disease. Chin Med J 126:3205–3208
Konecny T, Somers K, Orban M et al (2010) Interactions between COPD and outcomes after percutaneous coronary intervention. Chest 138:621–627
Koseoglu C, Kurmus O, Ertem AG et al (2016) Forced expiratory volume in one second can predict SYNTAX score in patients with chronic obstructive pulmonary disease. Kardiol Pol 74(6):584–590
Wang G, Hua Q, Li J et al (2016) Does SYNTAX score II predict poor myocardial perfusion in ST-segment elevation myocardial infarction. Cardiol J 23(3):317–323. doi:10.5603/CJ.a2016.0006
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Rights and permissions
About this article
Cite this article
Yesin, M., Çağdaş, M., Kalçık, M. et al. Comparison of syntax score and syntax score II to predict “no reflow phenomenon” in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging 33, 1883–1889 (2017). https://doi.org/10.1007/s10554-017-1200-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-017-1200-5